For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What is the projected market size of the endocrinology drugs industry, and what is its expected CAGR?
The endocrinology drugs market size has grown strongly in recent years. It will grow from $33.26 billion in 2024 to $36.21 billion in 2025 at a compound annual growth rate (CAGR) of 8.86%. The growth in the historic period can be attributed to increasing prevalence of diabetes globally, increasing government initiatives, increasing healthcare expenditure, increasing prevalence of adrenal gland disorders, a rise in demand for insulin analogs, and growth in the number of endocrinologists.
The endocrinology drugs market size is expected to see strong growth in the next few years. It will grow to $50.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.60%. The growth in the forecast period can be attributed to a growing diabetic population, increasing prevalence of endocrine disorders, a growing number of adolescents with hormonal imbalances, and rising obesity rates. Major trends in the forecast period include technological advancements, adoption of advanced drug delivery systems, integration of digital health solutions, precision medicine, and combination therapies.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20769&type=smp
What external factors are influencing the endocrinology drugs market’s growth momentum?
The rising prevalence of endocrine diseases is expected to propel the growth of the endocrinology drugs market going forward. Endocrine diseases are disorders that impact the endocrine system, causing imbalances in hormone production or regulation, which can interfere with normal bodily functions. The rising prevalence of endocrine diseases can be attributed to several factors, including lifestyle changes, an aging population, and improved diagnosis, which have all contributed to the increased recognition and incidence of these conditions. Endocrinology drugs help manage endocrine diseases by regulating hormone levels, addressing glandular dysfunction, and restoring hormonal balance to alleviate symptoms and improve overall health outcomes. For instance, in May 2023, according to the National Library of Medicine, a US-based medical library, approximately 13 million people in the United States, or 4.78% of the population, suffer from undiagnosed endocrine disorders. Among these, thyroid disease is one of the most prevalent endocrine disorders, accounting for approximately 30% to 40% of patients treated in endocrine practices. Therefore, the rising prevalence of endocrine diseases is driving growth in the endocrinology drugs market.
What are the major market segments driving the growth of the endocrinology drugs industry?
The endocrinology drugs market covered in this report is segmented –
1) By Indication: Hyperthyroidism, Hypothyroidism, Diabetes, Polycystic Ovarian Syndrome, Growth Hormone Disorders, Pituitary Gland Disorders, Other Indications
2) By Therapy Area: Diabetes Drugs, Thyroid Hormone Disorder Drugs, Human Growth Hormone, Testosterone Replacement Therapy, Others Therapy Areas
3) By Distribution Channel: Hospital pharmacies, Online Pharmacies, Retail pharmacies
4) By End User: Hospitals, Ambulatory Surgical Centers, Others End Users
Subsegments:
1) By Hyperthyroidism: Antithyroid Medications, Radioactive Iodine Therapy, Beta Blockers
2) By Hypothyroidism: Levothyroxine-based Medications, Liothyronine-based Medications, Combination Hormonal Therapies
3) By Diabetes: Insulin Therapies, Oral Antidiabetic Drugs (OADs), GLP-1 Receptor Agonists, SGLT-2 Inhibitors, DPP-4 Inhibitors
4) By Polycystic Ovarian Syndrome (PCOS): Oral Contraceptives, Metformin, Clomiphene Citrate, Anti-Androgens
5) By Growth Hormone Disorders: Recombinant Human Growth Hormone (rhGH), Growth Hormone Secretagogues, Growth Hormone Receptor Antagonists
6) By Pituitary Gland Disorders: Somatostatin Analogs, Gonadotropins, Dopamine Agonists
7) By Other Indications: Adrenal Gland Disorders, Osteoporosis, Parathyroid Disorders, Male Hormonal Imbalances
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/endocrinology-drugs-global-market-report
What are the key trends shaping the endocrinology drugs market in the forecast period?
Major companies operating in the endocrinology drugs market are focusing on developing innovative products such as ready-to-use vials to improve medication administration. Ready-to-use vials are pre-filled and pre-dosed medication containers that require no reconstitution or preparation before administration. For instance, in December 2022, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, launched Levothyroxine sodium injection in ready-to-use vials at a concentration of 100 mcg/mL. The formulation is designed for immediate use, eliminating the need for reconstitution and reducing the risk of preparation errors, thereby improving patient safety. It provides precise and consistent dosing, which is critical for managing conditions like hypothyroidism and myxedema coma. The ready-to-use vials also improve efficiency for healthcare providers, saving time and ensuring accurate administration in urgent care settings.
Who are the key market players contributing to the growth of the endocrinology drugs industry?
Major companies operating in the endocrinology drugs market are Johnson & Johnson Inc., Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Novartis International AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Biocon Limited, Boehringer Ingelheim International GmbH, Mylan N.V., Sandoz International GmbH, Ipsen Pharma, Ferring Pharmaceuticals Inc., Endocrine Pharma Private Limited
Which regions are leading the growth of the endocrinology drugs market globally?
North America was the largest region in the endocrinology drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrinology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Endocrinology Drugs Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20769
Need Customized Data On Endocrinology Drugs Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20769&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
